253 related articles for article (PubMed ID: 31403546)
41. Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F; Saraceno R; Chimenti S; Nistico S
Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
[TBL] [Abstract][Full Text] [Related]
42. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
43. Combination therapy of sirolimus and acitretin in solid organ transplant recipients: a new cutaneous adverse event.
Skillen LA; Corry A
Clin Exp Dermatol; 2019 Jan; 44(1):62-63. PubMed ID: 30430627
[No Abstract] [Full Text] [Related]
44. [Primary and secondary prevention of skin cancer in organ transplant recipients].
Lonsdorf AS; Becker MR; Stockfleth E; Schäkel K; Ulrich C
Hautarzt; 2010 Mar; 61(3):195-206. PubMed ID: 20177652
[TBL] [Abstract][Full Text] [Related]
45. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
46. De Novo Skin Neoplasms in Liver-Transplanted Patients: Single-Center Prospective Evaluation of 105 Cases.
Paganelli A; Magistri P; Kaleci S; Chester J; Pezzini C; Catellani B; Ciardo S; Casari A; Giusti F; Bassoli S; Di Sandro S; Pellacani G; Farnetani F; Di Benedetto F
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295604
[No Abstract] [Full Text] [Related]
47. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Nemer KM; Council ML
Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
[TBL] [Abstract][Full Text] [Related]
48. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
49. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
50. Vemurafenib-related cutaneous side effects ameliorated by acitretin.
Chon SY; Sambrano BL; Geddes ER
J Drugs Dermatol; 2014 May; 13(5):586-8. PubMed ID: 24809883
[TBL] [Abstract][Full Text] [Related]
51. Reducing skin malignancy risk in organ transplant recipients.
Francis S; Berg D
Skin Therapy Lett; 2013 Jan; 18(1):1-3. PubMed ID: 23474655
[TBL] [Abstract][Full Text] [Related]
52. Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.
Hasson A; Navarrete-Dechent C; Nicklas C; de la Cruz C
Indian J Dermatol Venereol Leprol; 2012; 78(4):448-53. PubMed ID: 22772615
[TBL] [Abstract][Full Text] [Related]
53. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Kadakia KC; Barton DL; Loprinzi CL; Sloan JA; Otley CC; Diekmann BB; Novotny PJ; Alberts SR; Limburg PJ; Pittelkow MR
Cancer; 2012 Apr; 118(8):2128-37. PubMed ID: 21882176
[TBL] [Abstract][Full Text] [Related]
54. Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Blomberg M; He SY; Harwood C; Arron ST; Demehri S; Green A; Asgari MM;
Br J Dermatol; 2017 Nov; 177(5):1225-1233. PubMed ID: 29086412
[TBL] [Abstract][Full Text] [Related]
55. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):263-279. PubMed ID: 21763562
[TBL] [Abstract][Full Text] [Related]
56. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
57. Skin Cancer in Solid Organ Transplant Recipients: A Review for the Nondermatologist.
Berman H; Shimshak S; Reimer D; Brigham T; Hedges MS; Degesys C; Tolaymat L
Mayo Clin Proc; 2022 Dec; 97(12):2355-2368. PubMed ID: 36334939
[TBL] [Abstract][Full Text] [Related]
58. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Arzeno J; Leavitt E; Lonowski S; Kim J
Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370
[No Abstract] [Full Text] [Related]
59. Efficacy of retinoids alone or in combination with other remedies in the management of warts: A systematic review and network meta-analysis.
Salman S; S A Shehata M; Ibrahim AM; Awad M; Sarsik S; El-Shirbiny H; Fathi M; Agha NY; Anis R; Abdel Daim MM
Dermatol Ther; 2021 Mar; 34(2):e14793. PubMed ID: 33480148
[TBL] [Abstract][Full Text] [Related]
60. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
Marquez C; Bair SM; Smithberger E; Cherpelis BS; Glass LF
J Drugs Dermatol; 2010 Jul; 9(7):753-8. PubMed ID: 20677528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
